Novel, Simple Method to Produce More & Better Human Plasma
Method for Production of Recombinant Human Plasminogen
Tags: Monash University, Australia, Healthcare & Lifesciences
This technology develops recombinant human plasminogen to improve wound healing and treat blood disorders, overcoming limitations of current plasma-derived products. It uses a mammalian expression system for higher yield and purity, crucial for therapeutic use. This method promises significant quantities of biologically active plasminogen, offering a safer, more efficient alternative for treating conditions like heterotopic ossification and diabetic wounds. The process is backed by patents in several regions, indicating its innovation and potential for medical application.
IP Type or Form Factor: Patent Pending; Process & Method
TRL: 3 - proof of concept with needs validated
Industry or Tech Area: Biotechnology; Healthcare Provider
